Medicamen Biotech Ltd
BSE : 531146
NSE : MEDICAMEQ
Sector :Health care
ISIN Code : INE646B01010
NSE
526.95
2.85 (0.54%)
Open
523.90
High
531.80
Low
517.15
BSE
525.95
0.95 (0.18%)
Open
525.00
High
530.95
Low
517.15
Board Meeting Intimation for Approval Of Audited Financial Results (Standalone & Consolidated) For The Quarter And Yearly Ended On 31.03.204
12:00 AM,3rd Jan 2025
MEDICAMEN BIOTECH LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 inter alia to consider and approve Audited Financial Results (Standalone & Consolidated) for the quarter & year ended on 31.03.2024 and to approve Final Dividend for the FY 2023-24.
